novo nordisk glp-1 receptor agonist medications GLP-1 diabetes drugs like Ozempic may modestly reduce cancer risks Novo Nordisk, Eli Lilly Slip

Additionally, vascular endothelium becomes less effective at regulating blood flow and preventing clot formation, leading to endothelial dysfunction, increasing the risk of atherosclerosis, thrombosis, and other vascular diseases

and device manufacturers such as Nemera (Astorg/Montagu)

Potential complications include acid reflux, hernias, nutritional deficiencies, dumping syndrome a condition that can lead to symptoms like nausea and dizziness and more

We prescribed semaglutide or liraglutide in accordance with Austrian reimbursement regulations

The prescribing information for these medications contains a boxed warning regarding the potential risk of thyroid C-cell tumors, a rare form of thyroid cancer

I was very excited, Wharton says